Maryland 2025 Regular Session

Maryland House Bill HB830 Compare Versions

Version 1 (Old)

Version 2 (New)

Old	New		Differences
1	1
2	2
3	3		EXPLANATION: CAPITALS INDICATE MAT TER ADDED TO EXISTIN G LAW.
4	4		[Brackets] indicate matter deleted from existing law.
5		-	Underlining indicates amendments to bill.
6		-	Strike out indicates matter stricken from the bill by amendment or deleted from the law by
7		-	amendment.
8	5		hb0830
9	6
10	7		HOUSE BILL 830
11	8		J5, J4 5lr1400
12	9		CF SB 476
13	10		By: Delegates D. Jones, White Holland, Bagnall, Fennell, Forbes, Guzzone, Kipke,
14		-	Ruth, and Wilkins Wilkins, Alston, Bhandari, Chisholm, Cullison, Hill,
15		-	Hutchinson, S. Johnson, Kaiser, Kerr, Lopez, Martinez, M. Morgan,
16		-	Pena–Melnyk, Reilly, Rosenberg, Ross, Szeliga, Taveras, Woods, and
17		-	Woorman
	11	+	Ruth, and Wilkins
18	12		Introduced and read first time: January 29, 2025
19	13		Assigned to: Health and Government Operations
20		-	Committee Report: Favorable with amendments
21		-	House action: Adopted
22		-	Read second time: March 6, 2025
23	14
24		-	~~CHAPTER ______~~
	15	+	A BILL ENTITLED
25	16
26	17		AN ACT concerning 1
27	18
28	19		Health Insurance – Genetic Testing and Cancer Imaging – Required Coverage 2
29	20		and Prohibited Cost–Sharing 3
30	21
31	22		FOR the purpose of requiring certain insurers, nonprofit health service plans, and health 4
32	23		maintenance organizations to provide coverage for genetic testing for certain 5
33	24		individuals who may have an increased risk of developing cancer and follow–up 6
34	25		evidence–based cancer imaging for individuals with an increased risk of developing 7
35	26		cancer; prohibiting certain insurers, nonprofit health service plans, and health 8
36	27		maintenance organizations from imposing a copayment, coinsurance, or deductible 9
37	28		requirement on coverage for genetic testing and follow–up evidence–based cancer 10
38	29		imaging; and generally relating to health insurance coverage for genetic testing and 11
39	30		cancer imaging. 12
40	31
41	32		BY adding to 13
42	33		Article – Insurance 14
43	34		Section 15–861 15
44	35		Annotated Code of Maryland 16
45	36		(2017 Replacement Volume and 2024 Supplement) 17
46	37
47	38		SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND, 18
48		-	That the Laws of Maryland read as follows: 19 2 HOUSE BILL 830
	39	+	That the Laws of Maryland read as follows: 19
	40	+
	41	+	Article – Insurance 20
	42	+
	43	+	15–861. 21
	44	+
	45	+	(A) THIS SECTION APPLIES TO: 22
	46	+	2 HOUSE BILL 830
49	47
50	48
	49	+	(1) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 1
	50	+	PROVIDE HOSPITAL , MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GROUP S 2
	51	+	ON AN EXPENSE –INCURRED BASIS UNDER HEALTH INSURANCE POL ICIES OR 3
	52	+	CONTRACTS THAT ARE I SSUED OR DELIVERED I N THE STATE; AND 4
51	53
52		-	Article – Insurance 1
	54	+	(2) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 5
	55	+	HOSPITAL, MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GR OUPS UNDER 6
	56	+	CONTRACTS THAT ARE I SSUED OR DELIVERED I N THE STATE. 7
53	57
54		-	~~15–861. 2~~
	58	+	(B) AN ENTITY SUBJECT TO THIS SECTION SHALL P ROVIDE COVERAGE FOR : 8
55	59
56		-	(A) THIS SECTION APPLIES TO: 3
	60	+	(1) GENETIC TESTING TO I DENTIFY WHETHER AN I NDIVIDUAL WITH A 9
	61	+	PERSONAL OR FAMILY H ISTORY OF CANCER HA S AN INHERITED MUTAT ION 10
	62	+	ASSOCIATED WITH AN I NCREASED RISK OF CAN CER IF THE GENETIC T ESTING IS: 11
57	63
58		-	(1) INSURERS AND NONPROF IT HEALTH SERVICE PL ANS THAT 4
59		-	PROVIDE HOSPITAL , MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GR OUPS 5
60		-	ON AN EXPENSE –INCURRED BASIS UNDER HEALTH INSURANCE POL ICIES OR 6
61		-	CONTRACTS THAT ARE I SSUED OR DELIVERED I N THE STATE; AND 7
	64	+	(I) RECOMMENDED BY A HEA LTH CARE PROFESSIONA L; AND 12
62	65
63		-	(2) HEALTH MAINTENANCE O RGANIZATIONS THAT PR OVIDE 8
64		-	HOSPITAL, MEDICAL, OR SURGICAL BENEFITS TO INDIVIDUALS OR GR OUPS UNDER 9
65		-	CONTRACTS THAT ARE I SSUED OR DELIVERED I N THE STATE. 10
	66	+	(II) CONSISTENT WITH EVID ENCE–BASED, CLINICAL PRACTICE 13
	67	+	GUIDELINES; AND 14
66	68
67		-	(B) AN ENTITY SUBJECT TO THIS SECTION SHALL P ROVIDE COVERAGE FOR : 11
	69	+	(2) IF AN INDIVIDUAL WHO UNDERGOES GENETIC TE STING FOR 15
	70	+	WHICH COVERAGE IS PR OVIDED UNDER ITEM (1) OF THIS SUBSECTION I S 16
	71	+	DETERMINED TO BE AT AN INCREASED RISK OF DEVELOPING CANCER , FOLLOW–UP 17
	72	+	EVIDENCE–BASED CANCER IMAGING THAT: 18
68	73
69		-	(1) GENETIC TESTING TO I DENTIFY WHETHER AN I NDIVIDUAL WITH A 12
70		-	PERSONAL OR FAMILY HISTORY OF CANCER HAS AN INHERI TED MUTATION 13
71		-	ASSOCIATED WITH AN I NCREASED RISK OF CAN CER IF THE GENETIC T ESTING IS: 14
	74	+	(I) IS RECOMMENDED FOR T HE TYPE OF CANCER ID ENTIFIED 19
	75	+	BY THE GENETIC TESTI NG; AND 20
72	76
73		-	(I) RECOMMENDED BY A HEA LTH CARE PROFESSIONA L; AND 15
	77	+	(II) USES MODALITIES ESTA BLISHED IN THE MOST RECENT 21
	78	+	VERSION OF THE NATIONAL COMPREHENSIVE CANCER NETWORK CLINICAL 22
	79	+	PRACTICE GUIDELINES IN ONCOLOGY. 23
74	80
75		-	(II) CONSISTENT WITH EVID ENCE–BASED, CLINICAL PRACTICE 16
76		-	GUIDELINES; AND 17
	81	+	(C) (1) EXCEPT AS PROVIDED IN PARAGRAPH (2) OF THIS SUBSECTION , 24
	82	+	AN ENTITY SUBJECT TO THIS SECT ION MAY NOT IMPOSE A COPAYMENT , 25
	83	+	COINSURANCE , OR DEDUCTIBLE REQUIR EMENT ON COVERAGE FO R GENETIC 26
	84	+	TESTING OR FOLLOW –UP EVIDENCE –BASED CANCER IMAGING AS DESCRIBED IN 27
	85	+	SUBSECTION (B) OF THIS SECTION. 28
77	86
78		-	(2) IF AN INDIVIDUAL WHO UNDERGOES GENETIC TE STING FOR 18
79		-	WHICH COVERAGE IS PR OVIDED UNDER ITEM (1) OF THIS SUBSECTION I S 19
80		-	DETERMINED TO BE AT AN INCREASED RISK OF DEVELOPING CANCER , FOLLOW–UP 20
81		-	EVIDENCE–BASED CANCER IMAGING THAT: 21
82		-
83		-	(I) IS RECOMMENDED FOR THE TYPE OF CANCER I DENTIFIED 22
84		-	BY THE GENETIC TESTI NG; AND 23
85		-
86		-	(II) USES MODALITIES ESTA BLISHED IN THE MOST RECENT 24
87		-	VERSION OF THE NATIONAL COMPREHENSIVE CANCER NETWORK CLINICAL 25
88		-	PRACTICE GUIDELINES IN ONCOLOGY. 26
89		-
90		-	(C) (1) EXCEPT AS PROVIDED IN PARAGRAPH (2) OF THIS SUBSECTION , 27
91		-	AN ENTITY SUBJECT TO THIS SECTION MAY NOT IMPOSE A COPAYMENT , 28
92		-	COINSURANCE , OR DEDUCTIBLE REQUIR EMENT ON COVERAGE FO R GENETIC 29
93		-	TESTING OR FOLLOW –UP EVIDENCE –BASED CANCER IMAGING AS DESCRIBED IN 30
94		-	SUBSECTION (B) OF THIS SECTION. 31 HOUSE BILL 830 3
	87	+	(2) (I) IF THE APPLICATION OF THE REQUI REMENTS UNDER 29
	88	+	PARAGRAPH (1) OF THIS SUBSECTION W OULD RESULT IN HEALT H SAVINGS 30
	89	+	ACCOUNT INELIGIBILIT Y UNDER 26 U.S.C. § 223, THE REQUIREMENT SHAL L APPLY 31
	90	+	TO THE HEALTH SAVING S ACCOUNT–QUALIFIED HIGH DEDUC TIBLE HEALTH PLANS 32 HOUSE BILL 830 3
95	91
96	92
	93	+	WITH RESPECT TO THE DEDUCTIBLE OF TH E PLAN AFTER THE BEN EFICIARY 1
	94	+	SATISFIES THE MINIMU M DEDUCTIBLE UNDER 26 U.S.C. § 223. 2
97	95
98		-	(2) (I) IF THE APPLICATION OF T HE REQUIREMENTS UNDE R 1
99		-	PARAGRAPH (1) OF THIS SUBSECTION W OULD RESULT IN HEALT H SAVINGS 2
100		-	ACCOUNT INELIGIBILIT Y UNDER 26 U.S.C. § 223, THE REQUIREMENT SHAL L APPLY 3
101		-	TO THE HEALTH SAVING S ACCOUNT–QUALIFIED HIGH DEDUC TIBLE HEALTH PLANS 4
102		-	WITH RESPECT TO THE DEDUCTI BLE OF THE PLAN AFTE R THE BENEFICIARY 5
	96	+	(II) FOR ITEMS OR SERVICES THAT ARE PREVENTIVE CARE IN 3
	97	+	ACCORDANCE WITH 26 U.S.C. § 223(C)(2)(C), THE REQUIREMENTS OF THIS 4
	98	+	SUBSECTION SHALL APP LY REGARDLESS OF WHE THER THE BENEFICIARY STAT US 5
103	99		SATISFIES THE MINIMU M DEDUCTIBLE UNDER 26 U.S.C. § 223. 6
104	100
105		-	(II) FOR ITEMS OR SERVICES THAT ARE PREVENTIVE CARE IN 7
106		-	ACCORDANCE WITH 26 U.S.C. § 223(C)(2)(C), THE REQUIREMENTS OF THIS 8
107		-	SUBSECTION SHAL L APPLY REGARDLESS O F WHETHER THE BENEFI CIARY STATUS 9
108		-	SATISFIES THE MINIMU M DEDUCTIBLE UNDER 26 U.S.C. § 223. 10
	101	+	SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 7
	102	+	policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 8
	103	+	after January 1, 2026. 9
109	104
110		-	SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall apply to all 11
111		-	policies, contracts, and health benefit plans issued, delivered, or renewed in the State on or 12
112		-	after January 1, 2026. 13
	105	+	SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take e ffect 10
	106	+	January 1, 2026. 11
113	107
114		-	SECTION 3. AND BE IT FURTHER ENACTED, That this Act shall take effect 14
115		-	January 1, 2026. 15
116		-
117		-
118		-
119		-
120		-	Approved:
121		-	________________________________________________________________________________
122		-	Governor.
123		-	________________________________________________________________________________
124		-	Speaker of the House of Delegates.
125		-	________________________________________________________________________________
126		-	President of the Senate.